Presently, over 100 CMOs across the globe claim to have manufacturing facilities in China..

A growing economy, large population base, and innovation-friendly environment are other key parameters that are anticipated to drive the growth of the pharmaceutical contract manufacturing market in China. Further, in order to meet the growing demand for their services, CMOs having manufacturing facilities in China are actively expanding their existing capacities and capabilities in the region.
 
To order this 200+ page report, which features 85+ figures and 100+ tables, please visit this link 
 
The USD 13 billion (by 2030) financial opportunity within the pharmaceuticals contract manufacturing market in China has been analyzed across the following segments:
Key Geographical Regions
  • Eastern China
  • Southern China
  • Northern China
Type of Product
  • Active Pharmaceutical Ingredients (APIs)
  • Drug Products
Type of Drug Product
  • Solid
  • Liquid / Semi-Solid
  • Injectable
  • Others
Scale of Operation
  • Clinical
  • Commercial
Company Size
  • Small
  • Mid-Sized
  • Large / Very Large
 
The China Pharmaceutical Contract Manufacturing Services Market, 2020-2030 report features the following companies, which we identified to be key players in this domain: 
  • 2Y-Chem
  • Aurisco Pharmaceutical
  • ChemPartner
  • Dorrapharma
  • Hubei Biocause Pharmaceutical
  • Infoark
  • Ningbo Menovo Pharmaceutical
  • Shandong Xinhua Pharmaceutical
  • Shanghai Acebright Pharmaceuticals
  • STA Pharmaceutical
  • Zhejiang Huahai Pharmaceutical
 
Table of Contents
 
1. Preface

2. Executive Summary

3. Introduction


4. Case Study: Comparison of Small Molecules and Large Molecules


5. Market Overview


6. Manufacturing Facilities of Pharmaceutical CMOs in China


7. Pharmaceutical Manufacturing Regulations in China


8. Company Profiles


9. Big Pharma Initiatives in China


10. Recent Trends


11. Capacity Analysis


12. SWOT Analysis


13. Market Forecast
 
14. Case Study: Impact of Coronavirus Outbreak


14. Conclusion
15. Executive Insights
16. Appendix 1: Tabulated Data
17. Appendix 2: List of Companies and Organizations
 
To purchase a copy, please visit https://www.rootsanalysis.com/reports/view_document/china-pharmaceutical-contract-manufacturing/312.html
 
Contact Details
Gaurav Chaudhary
+1 (415) 800 3415
[email protected]

You may also like

Discussion

No comments yet... Be the first to leave a reply! Login here

avatar
BenJ
0 Karma
901 Posts

Made with by Mamby